Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...
Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...
The early stage company is developing a new approach to gene editing to treat rare genetic diseases. It does this using mRNA, ...
Maravai LifeSciences, Inc. , a global provider of life science reagents and services to researchers and biotech innovators, announced today its acquisition of intellectual property and relevant assets ...
Pharmaceutical Logistics Transportation Service Market Strength Builds At 5.87% CAGR, Hitting 494.9 Billion USD By 2032 The global pharmaceutical logistics transportation service market is projected ...
Vertex Pharmaceuticals won approval from the U.S. Food and Drug Administration for a non-opioid pain drug, clearing the way ...
"The biggest CRISPR challenge is delivery ... gooey shells that protect mRNA vaccines, for example. The main advantage Editpep's technology has, Foss said, is that its molecules are smaller ...
Ahead of Robert F. Kennedy Jr.’s confirmation hearings, experts—and RFK’s own family—expressed concerns about his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback